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Cdc42 homologous protein (Chp) is a member of the Rho family of small GTPases and shares significant sequence and
functional similarity with Cdc42. However, unlike classical Rho GTPases, we recently found that Chp depends on
palmitoylation, rather than prenylation, for association with cellular membranes. Because palmitoylation alone is
typically not sufficient to promote membrane association, we evaluated the possibility that other carboxy-terminal
residues facilitate Chp subcellular association with membranes. We found that Chp membrane association and trans-
forming activity was dependent on the integrity of a stretch of basic amino acids in the carboxy terminus of Chp and that
the basic amino acids were not simply part of a palmitoyl acyltransferase recognition motif. We also determined that the
11 carboxy-terminal residues alone were sufficient to promote Chp plasma and endomembrane association. Interestingly,
stimulation with tumor necrosis factor- activated only endomembrane-associated Chp. Finally, we found that Chp
membrane association was not disrupted by Rho guanine nucleotide dissociation inhibitory proteins, which are negative
regulators of Cdc42 membrane association and biological activity. In summary, the unique carboxy-terminal sequence
elements that promote Chp subcellular location and function expand the complexity of mechanisms by which the cellular
functions of Rho GTPases are regulated.
INTRODUCTION
Cdc42 homologous protein (Chp; also called Wrch-2) is a
recently identified member of the Rho family of small GTP
binding and hydrolyzing proteins (Aronheim et al., 1998). To
date, the best-characterized Rho family small GTPases are
RhoA, Rac1, and Cdc42 (Wennerberg and Der, 2004). Al-
though Chp exhibits strong sequence, biochemical, and
functional similarities with Cdc42, Chp possesses additional
30-amino acid amino- and carboxy-terminal sequences not
found in Cdc42 or other canonical Rho family GTPases.
Furthermore, Chp lacks the carboxy-terminal CAAX (C, cys-
teine; A, aliphatic acid; X, terminal amino acid) tetrapeptide
motif that is critical for the function of Cdc42 and other Ras
and Rho GTPases and instead terminates in a tripeptide
cysteine-phenylalanine-valine sequence.
The presence of a carboxy-terminal CAAX sequence is
critical for initiating a series of posttranslational modifica-
tions that promote the association of CAAX-containing pro-
teins with the plasma or other cellular membranes (Cox and
Der, 1992; Casey and Seabra, 1996; Fu and Casey, 1999).
These modifications include 1) covalent modification of the
cysteine residue by a geranylgeranyl or farnesyl isoprenoid
lipid, 2) Rce1-catalyzed proteolytic removal of the -AAX
residues, and 3) carboxylmethylation of the now terminal
prenylated cysteine (Ashby et al., 1992; Otto et al., 1999).
CAAX-directed processing increases the overall hydropho-
bicity of the carboxy terminus of the protein (Der and Cox,
1991; Cox and Der, 1992; Casey and Seabra, 1996; Fu and
Casey, 1999), and prevention of these modifications renders
Rho GTPases cytosolic and nonfunctional (Murphy et al.,
1999; Allal et al., 2000; Solski et al., 2002; Joyce and Cox,
2003). The importance of isoprenoid modification in Rho
GTPase function is also indicated by the regulatory mecha-
nism of Rho guanine nucleotide dissociation inhibitors
(RhoGDIs; , , and ) (DerMardirossian and Bokoch, 2005).
RhoGDIs recognize and mask the isoprenoid group at the
carboxy terminus of the Rho GTPase, rendering it cytosolic
and inactive. Whether RhoGDIs regulate all members of the
Rho GTPase family has not been determined.
Although CAAX-signaled modifications are necessary for
Rho GTPase membrane association and function, these mod-
ifications alone are not sufficient to promote proper subcel-
lular localization and full biological activity (Hancock et al.,
1990). Two distinct motifs immediately upstream of the
CAAX box have also been implicated in promoting mem-
brane association and are therefore characterized as second-
ary membrane-targeting signals. The secondary signal may
comprise either a cysteine residue that is posttranslationally
modified by a palmitate fatty acid or a polybasic amino acid
sequence (Hancock et al., 1990; Mitchell et al., 1994; Dudler
and Gelb, 1996; Coats et al., 1999). The presence of one of
these two motifs, together with prenylation, is necessary and
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sufficient for proper localization and biological function of
Ras and Rho small GTPases.
The nature of these second signals was first established
with CAAX-containing and membrane-localized Ras pro-
teins. Mutation of the cysteine residues upstream of the
CAAX motif of H-Ras did not impair CAAX-signaled pre-
nylation but nevertheless caused mislocalization of H-Ras to
endomembranes and impairment of transforming activity
(Hancock et al., 1989). Similarly, pharmacological inhibition
of palmitoylation caused H-Ras to mislocalize to endomem-
branes (Michaelson et al., 2002). Furthermore, mutation of
lysine basic residues adjacent to the CAAX motif of acti-
vated K-Ras4B did not prevent the prenyl modification of
K-Ras4B, but nonetheless rendered the protein partially cy-
tosolic and caused a near total elimination of its transform-
ing activity (Hancock et al., 1990; Jackson et al., 1994). Sub-
sequent studies firmly established the role of palmitoylated
cysteines (e.g., RhoB and TC10) or basic residues (e.g., Rac1)
as second signals important for the proper membrane tar-
geting and function of Rho family GTPases (Mitchell et al.,
1994; Dudler and Gelb, 1996; Coats et al., 1999).
We recently reported that Chp, which lacks a canonical
CAAX motif, is still dependent on an intact carboxy termi-
nus for biological activity and association with the plasma
membrane (Chenette et al., 2005). We found that mutation of
the terminal cysteine resulted in cytoplasmic mislocalization
of Chp, analogous to phenotype of a corresponding “SAAX”
mutation in Cdc42. Unlike Cdc42, we found that Chp local-
ization and transforming activity depends on palmitoylation
rather than prenylation, indicating that Chp membrane as-
sociation is mediated by a novel posttranslational processing
pathway that takes advantage of palmitoylation as the sole
carboxyl-terminal lipid modification. Similarly, we also de-
termined that a Chp-related GTPase, Wrch-1, also depends
on palmitoylation, and not prenylation, for proper mem-
brane association and function (Berzat et al., 2005). Thus,
although Chp and Wrch-1 share functional similarities with
Cdc42, they diverge significantly in their mode of membrane
association.
Recent studies emphasize the critical role of carboxy-ter-
minal variation in supporting functionally distinct roles for
otherwise highly related Rho GTPases. For example, al-
though RhoA, RhoB, and RhoC share strong sequence iden-
tity, exhibit essentially identical intrinsic biochemical prop-
erties, and interact with common regulators and effectors,
they serve unique roles in cell physiology (Wheeler and
Ridley, 2004). The plasma membrane-associated RhoA is a
regulator of actomyosin contractility, whereas endosome-
associated RhoB regulates cytokine trafficking and cell sur-
vival, and RhoC is important in cell locomotion and has
been implicated in cancer cell invasion and metastasis. Di-
vergence in carboxy-terminal sequences account for their
distinct subcellular locations, membrane interactions, and
biological activities (Wang et al., 2003). Similarly, the unique
carboxy-terminal sequence and lipid modifications of Chp
likely distinguish it functionally from the otherwise highly
related Cdc42. Further delineation of the nature of Chp
carboxy-terminal sequences and their role in Chp biological
function will be needed to address this possibility.
In this study, we found that the carboxy terminus of Chp
is necessary for recruitment of Chp effectors to distinct mem-
brane locations. We identified multiple carboxy-terminal se-
quences important for mediating Chp subcellular location
and biological activity, because palmitoylation alone was
not sufficient to promote Chp membrane association and
function. We found that basic residues as well as an invari-
ant tryptophan residue were not required for Chp modifi-
cation by palmitoylation, yet were critical for Chp subcellu-
lar location and transforming activity. The terminal 11
amino acids of Chp, which contain the palmitoylated cys-
teine as well as conserved tryptophan and basic amino acids
were sufficient to target green fluorescent protein (GFP) to
the plasma and endomembranes. Additionally, we found
that RhoGDIs failed to prevent Chp membrane association.
Thus, although Chp and Cdc42 share significant biochemical
similarity, their considerable divergence in carboxy-termi-
nal–mediated membrane targeting and subcellular location
help explain their unique roles in cell physiology.
MATERIALS AND METHODS
Molecular Constructs and Reagents
Mammalian Chp expression vectors were generated by fusing cDNA se-
quences encoding Chp, Chp[G40V], and N-Chp[G40V] in frame with amino-
terminal sequences encoding a hemagglutinin (HA) epitope tag in pBabe-
puro-HAII retrovirus expression vector (a generous gift from Teresa Grana,
University of North Carolina at Chapel Hill, Chapel Hill, NC) or in frame with
amino-terminal sequences encoding green fluorescent protein (GFP) in the
pEGFP-c3 expression vector (Clontech, Mountain View, CA). Further mis-
sense mutations were created by engineering the appropriate mutation dur-
ing PCR-mediated DNA amplification to encode the 226Q, 228Q, 229Y, 230Q,
and/or 231Q missense mutations in wild-type, activated (G40V), or activated
and amino-terminally truncated [N-Chp(40V]). Oligonucleotide DNA se-
quences designed to engineer the appropriate mutations are as follows: 5-GGT-
GTGCGCACGGCCTCTCGCTGTCGC-3 for a corresponding 224A mutant; 5-
GTGCGCACGCTCGCTCGCTGTCGCTGG-3 for a corresponding 225A mutant;
5-CGCACGCTCTCTCAGTGTCGCTGGAAG-3 for a corresponding 226Q mu-
tant; 5-CTCTCTCGCTGTCAGTGGAAGAAGTTC-3 for a corresponding 228Q
mutant; CGCACGCTCTCTCAGTGTCAGTGGAAGAAGTTC-3 for a corre-
sponding 226Q/228Q mutant; 5-CTCTCGCTGTCGCTATAAGAAGTTCTTCTG-
C-3 for a corresponding 229Y mutant; 5-CGCTGGCAGAAGTTCTTCTGC-3 for a
corresponding 230Q mutant; 5-CGCTGGAAGCAGTTCTTCTGC-3 for a corre-
sponding 231Q mutant; 5-CGCTGGCAGCAGTTCTTCTGC-3 for a corresponding
230Q/231Q mutant; and 5-ACGCTCTCTCAATGTCAATGGCAGCAGTTCTTC-
TGC-3 for the corresponding 4Q mutant. Truncation mutants were created by
designing oligonucleotide primers for PCR-mediated DNA amplification of the
appropriate length of Chp carboxy-terminal sequence, and fusing the PCR product
in a pEGFP-c3 expression vector. pcDNA3.1-RhoGDI expression vectors were ob-
tained from the Guthrie cDNA Resource (Sayre, PA).
The yellow fluorescent protein (YFP)-p21 activated kinase (PAK)-p21 bind-
ing domain (PBD) probe was generated by fusing a cDNA sequence encoding
the Cdc42/Rac PBD of human PAK1 in frame with the amino-terminal YFP
sequence in a pcDNA3-YFP expression vector (Mitin et al., 2004). The PBD
corresponds to amino acids 74-133 of PAK1 and was cloned into pcDNA3-
YFP in 5EcoRI and 3XhoI restriction sites. Oligonucleotide primers used to
amplify PAK-PBD are as follows: 5-GCGGAATTCGAGATTTGTCTCCC-3
and 5-GCGTATTTACCTCGAGGATTACGAGTTGTA-3.
Tissue Culture and Transformation Assays
NIH 3T3 cells were maintained in DMEM supplemented with 10% calf serum
(Sigma-Aldrich, St. Louis, MO), and 100 U/ml penicillin and 100 g/ml
streptomycin (designated growth medium). Unless otherwise indicated, cells
were fed every 2 d with 4 ml of growth medium.
To evaluate anchorage-independent growth in soft agar, we first estab-
lished mass populations of NIH 3T3 cells that were stably transfected with the
empty pBabe-HAII expression vector or vectors encoding wild-type (WT)
Chp, N-Chp(40V), N-Chp(40V/229Y), N-Chp(40V/230Q), or N-Chp
(40V/231Q). NIH 3T3 cells stably expressing wild type or mutant Chp
proteins were used in soft agar assays according to procedures described
previously (Cox and Der, 1994; Clark et al., 1995; Solski et al., 2000). Colony
formation was quantitated and photographed after 35 d. Expression of HA-
tagged wild-type or mutant Chp in stably transfected mass populations of
NIH 3T3 cells was assessed by Western blot with the rat anti-HA 3F10
antibody (Roche Diagnostics, Indianapolis, IN). Comparable protein loading
was verified using an anti--actin antibody (clone AC-15; Sigma-Aldrich).
Fluorescence Microscopy
For GFP-Chp localization analyses, NIH 3T3 cells grown in growth medium
were seeded in 35-mm glass-bottomed plates (MatTek, Ashland, MA). Cells
were transiently transfected with 0.5 g of the pEGFP-c3 constructs using
Lipofectamine Plus lipid transfection reagents (Invitrogen, Carlsbad, CA).
Three hours after transfection, cells were washed and grown in phenol
red-free DMEM/F-12 supplemented with 10% calf serum. Live cells were
viewed 20 h after transfection using a Zeiss 510 LSM confocal microscope.
Images were captured using the Zeiss LSM 510 imaging software, and bright-
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Figure 1. TNF-–stimulated activation of endomembrane-associated Chp. (A) YFP-PAK-PBD colocalizes with activated Rac and Cdc42
small GTPases. NIH 3T3 cells were transiently transfected with 100 ng of YFP-PAK-PBD and 1 g of the indicated pcDNA 3.1 construct
[vector, Rac1, Rac1(17N), Rac1(61L), or Cdc42(61L)]. YFP fluorescence in live cells was visualized 20 h after transfection using a Zeiss 510 LSM
confocal microscope, and 0.4-m Z-slices were captured. Images shown are representative of at least two independent experiments, with 30
cells examined in each assay. YFP-PAK-PBD localized to the cytoplasm in cells that express vector, Rac1, or dominant negative Rac1(17N).
Expression of constitutively active Rac1(61L) recruited YFP-PAK-PBD to membrane ruffles (arrows), whereas Cdc42(61L) recruited PAK-PBD
to Golgi and plasma membranes (arrows). (B) Constitutively activated Chp recruits YFP-PAK-PBD to distinct cellular domains. NIH 3T3 cells
were transiently transfected with 100 ng of YFP-PAK PBD and 1 g of the indicated pcDNA3 construct [vector, Chp, Chp(40V), N-Chp(40V),
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ness/contrast adjustments were made in Adobe Photoshop (Adobe Systems,
Mountain View, CA).
For PAK-PBD recruitment studies, live cells were plated as described above
and transfected with 100 ng of pcDNA3-YFP-PAK-PBD and 1 g of the indicated
pcDNA-Chp expression vector using Lipofectamine Plus. Three hours after
transfection, cells were washed and grown in phenol red-free DMEM/F-12
supplemented with 0.5% calf serum overnight. Cells were treated with 10 ng/ml
tumor necrosis factor (TNF)- (Roche Diagnostics) for 15 min at 37°C where
indicated. Cells were viewed live as described above, 0.4-m Z-slices were
captured using the Zeiss LSM 510 imaging software, and brightness/contrast
adjustments were made in Adobe Photoshop.
For RhoGDI localization studies, live cells were plated and transfected as
described above and visualized using a Zeiss 510 LSM confocal microscope.
Images were captured using the Zeiss LSM 510 imaging software and bright-
ness/contrast adjustments were made in Adobe Photoshop.
1-Biotinamido-4-[4-(maleimidomethyl)
Cyclohexanecarboxamido] Butane (Biotin-BMCC) Labeling
Direct analyses of protein palmitoylation were done as described in Drisdel
and Green (2004). Briefly, 293T cells were transfected with 7 g of the
indicated pEGFP construct using a calcium phosphate transfection technique.
Forty-eight hours after transfection, cells were lysed in lysis buffer and
incubated with 5 g of anti-GFP monoclonal antibody (JL-8; Clontech) at 4°C
for 1 h, at which point 20 g of protein G (Invitrogen) was added to the lysates
and incubated at 4°C for 1 h. Bound protein was washed and incubated with
lysis buffer containing 50 mM N-ethylmaleimide (Sigma-Aldrich) for 48 h at
4°C. Bound protein was then washed and treated with 1 M hydroxylamine,
pH 7.4, to cleave thioester bonds for 1 h at 25°C, washed again, and treated
with biotin-BMCC (Pierce Chemical, Rockford, IL), which recognizes free
sulfhydryl groups, for 2 h at 25°C. Bound protein was washed again, resus-
pended in 50 l of 2 sample loading buffer, and resolved by 12% SDS-PAGE
and transferred to polyvinylidene difluoride membrane. Labeled protein was
detected by incubating with streptavidin-horseradish peroxidase (HRP;
Pierce Chemical), and membrane was washed and exposed to x-ray film.
Twenty microliters of lysate was resolved by SDS-PAGE, transferred, incubated
with anti-GFP primary antibody and anti-mouse IgG-HRP secondary antibody,
and exposed to x-ray film to verify the presence of all GFP-tagged proteins.
RESULTS
TNF- Causes Activation of Endomembrane-associated Chp
Our previous studies indicated the critical requirement of an
intact carboxy terminus in promoting Chp membrane asso-
ciation and transforming activity (Chenette et al., 2005). To
evaluate the importance of the carboxy terminus in promot-
ing effector interactions, we created a novel fluorescent
probe to detect the subcellular location of activated, GTP-
bound Chp. This technique involved designing a probe
similar to the fluorescent probe developed by Philips and
colleagues to demonstrate Ras activation on internal
membranes (Bivona et al., 2003). An advantage of this ap-
proach for evaluating Chp activation, when compared with
the standard pull-down assay, is the unbiased spatial deter-
mination of Chp activity (Philips, 2005). A potential limita-
tion of this approach is that it is not sensitive enough to
detect activation of endogenous GTPase activation. How-
ever, this limitation can be exploited to selectively evaluate
activation of a specific GTPase that is expressed ectopically.
The p21-binding domain of the PAK1 serine/threonine ki-
nase (PAK-PBD) binds preferentially to the activated, GTP-
bound forms of Chp as well as Cdc42 and Rac1 and has been
used for the development of fluorescence-based sensors for
Rac1 and Cdc42 activation (Kraynov et al., 2000; Itoh et al.,
2002). We created a fusion protein where the yellow fluo-
rescent protein (YFP) was added to the amino terminus of
PAK-PBD (YFP-PAK-PBD) and then evaluated the ability of this
probe to determine the subcellular localization of activated Rho
GTPases.
We initially performed analyses to verify the specificity of
the probe for detection of the activated forms of Rac1 and
Cdc42. When coexpressed with empty vector, YFP-PAK-PBD
was localized to the cytoplasm and nucleus of cells (Figure 1A).
No plasma membrane or endomembrane association was seen.
As expected, coexpression of wild-type Rac1 or dominant neg-
ative Rac1(17N), both GDP-bound, did not cause any reorga-
nization of YFP-PAK-PBD. However, expression of constitu-
tively active GTP-bound Rac1(61L) recruited YFP-PAK-PBD to
lamellipodia, which is a canonical site of activated Rac1 local-
ization. This result is similar to that seen with other fluores-
cence-based PAK-PBD probes for Rac activation (Itoh et al.,
2002). Likewise, expression of constitutively active Cdc42(61L)
recruited YFP-PAK-PBD to the plasma and Golgi membranes,
which are known sites of activated Cdc42 localization
(Michaelson et al., 2001; Aspenstrom et al., 2004). These results
verified that YFP-PAK-PBD can detect the activated GTP-
bound forms of Rac1 and Cdc42 in their specific subcellular
locations.
We next evaluated the ability of Chp to recruit YFP-PAK-
PBD to distinct cellular domains. We previously determined
that wild-type and activated Chp are both localized to
plasma and endomembranes (Chenette et al., 2005). As ex-
pected, expression of wild-type, presumably GDP-bound
Chp did not alter the cytoplasmic location of YFP-PAK-PBD
(Figure 1B). Expression of Chp(40V) likewise did not appre-
ciably alter localization of YFP-PAK-PBD, which is in keep-
ing with our previous results that found that Chp(40V) had
only modest transforming activity above that of wild-type
Chp (Chenette et al., 2005). However, expression of amino-
terminally truncated, GTPase-deficient N-Chp(40V) that
we previously determined to have potent transforming ac-
tivity was able to recruit a portion of YFP-PAK-PBD to
punctate endomembrane structures, reminiscent of the en-
dosomal localization of Chp. An intact carboxy terminus
was required for YFP-PAK-PBD recruitment, because the
putative constitutively GTP-bound N/C-Chp(40V) mu-
tant was not able to cause redistribution of YFP-PAK-PBD to
endomembranes. Deletion of the carboxy terminus was
shown previously to impair PAK1 binding (Aronheim et al.,
1998) as well as Chp localization and cellular transformation
(Chenette et al., 2005). Thus, the ability of the different Chp
variants to cause YFP-PAK-PBD redistribution correlated
directly with their transforming activity.
Previous analyses found that TNF- stimulation of c-Jun
NH2-terminal kinase (JNK) activation was impaired by ec-
topic expression of a putative Chp dominant negative pro-
tein (Aronheim et al., 1998). This observation suggests that
TNF- may stimulate Chp activation. To address this di-
rectly, we next determined whether TNF- treatment would
cause Chp-dependent relocalization of YFP-PAK-PBD. The
localization of GFP-Chp was examined in cells that were
Figure 1 (cont). or N/C-Chp(40V)]. YFP fluorescence in live
cells was visualized 20 h after transfection using a Zeiss 510 LSM
confocal microscope, and 0.4-m Z-slices were captured. Images
shown are representative of at least two independent experiments,
with 30 cells examined in each assay. YFP-PAK-PBD is localized to
the cytoplasm in cells that express vector, wild-type Chp, Chp(40V),
and N/C-Chp(40V). Expression of N-Chp(40V) recruited PAK-
PBD to discrete and punctate intercellular domains (arrow), remi-
niscent of Chp localization. Treatment of cells that expressed vector
or N/C-Chp(40V) with 10 ng/ml TNF- for 15 min did not alter
cytoplasmic localization of PAK-PBD. Wild-type Chp and Chp(40V)
recruited YFP-PAK-PBD to endomembrane structures following
TNF- treatment. YFP-PAK-PBD retained its endomembrane local-
ization in cells that expressed N-Chp(40V) after TNF- treatment.
(C) TNF- signaling does not cause redistribution of wild-type
GFP-Chp. NIH 3T3 cells were transiently transfected with 1 g of
pEGFP-Chp and left untreated or stimulated with 10 ng/ml TNF-.
Images were captured as described above 15 min after treatment.
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stimulated with TNF- to ensure that extracellular stimula-
tion did not affect Chp localization (Figure 1C). We next
treated cells that coexpressed YFP-PAK-PBD and wild-type
or mutant Chp with TNF- to assess the requirement for an
intact carboxy or amino terminus in TNF-–mediated acti-
vation of Chp. The addition of TNF- did not alter the
localization of YFP-PAK-PBD in cells that also expressed
control empty vector or vector encoding N/C-Chp(40V)
compared with untreated cells (Figure 1B). TNF- treatment
did not alter the punctate endomembrane localization of
cells that expressed active N-Chp(40V). Interestingly, we
observed a redistribution of YFP-PAK-PBD to punctate en-
domembrane, but not plasma membrane, structures upon
TNF- treatment in cells that expressed wild-type Chp or
Chp(40V), suggesting that TNF- treatment activated endo-
membrane-associated Chp. These results indicate that endo-
membrane-associated Chp possesses effector binding and
signaling activity.
Figure 2. TNF- causes prolonged Chp activation at the endomembrane. NIH 3T3 cells were transiently transfected with 1 g of the
indicated pcDNA construct [vector, Chp, N-Chp(40V), or Rac1] together with 100 ng of YFP-PAK-PBD. Twenty hours after transfection,
cells were then either incubated with growth medium (untreated) or growth medium supplemented with 10 ng/ml TNF-. YFP fluorescence
in live cells was visualized at the indicated times by using a Zeiss 510 LSM confocal microscope, and 0.4-m Z-slices were captured. Images
shown are representative of at least two independent experiments, with 30 cells examined in each assay. Arrows indicate Rac1-mediated
recruitment of YFP-PAK-PBD to membrane structures (arrows) with concomitant clearing of cytoplasm.
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To determine the kinetics of TNF-–mediated recruitment
of YFP-PAK-PBD, we analyzed PAK-PBD location in live
cells that coexpressed Chp, constitutively active Chp, and
Rac1 for 60 min after stimulation with TNF- (Figure 2). As
expected, the localization of YFP-PAK-PBD did not change
appreciably over the course of 60 min in cells that coex-
pressed vector or constitutively active N-Chp(40V). TNF-
–mediated stimulation of Rac1 promoted transient redis-
tribution of YFP-PAK-PBD, with PAK-PBD occurring at cell
membranes after 15 min. After 30 min, the majority of YFP-
PAK-PBD had returned to the cytoplasm in cells that coex-
pressed Rac1. After 60 min, the Rac1-expressing cells were
indistinguishable from untreated cells. TNF-–mediated
stimulation of Chp promoted recruitment to endomembrane
structures after 15 min. Unlike Rac1, coexpression of Chp
caused YFP-PAK-PBD to persist at endomembrane struc-
tures for over 60 min in stimulated cells. TNF- stimulation
did not affect localization of GFP-Chp during the course of
the experiment (Figure 1C; our unpublished data).
Basic Residues are Critical for Chp Subcellular Location
Our previous studies determined that palmitate modifica-
tion of cysteine 234 in the carboxy terminus of Chp was
critical for membrane association and transforming activity.
Because palmitate modification alone is not expected to be
sufficient for full Chp membrane targeting (Mitchell et al.,
1994; Booden et al., 1999; Dong et al., 2003), we evaluated a
possible role for basic residues adjacent to cysteine 234 in
Chp processing and localization.
As seen in Figure 3A, the positions of three basic amino
acid residues are completely conserved between the various
Chp orthologues and between the closely related Wrch-1
proteins: Arg-226, Lys-230, and Lys-231 (arrows). A fourth
basic residue, Arg-228, is present in only a subset of Chp/
Wrch-1 proteins (asterisk). We hypothesize that these con-
served residues, in particular the tandem Lys residues at
positions 230 and 231, are important for Chp localization to
the plasma membrane. Previous studies substituted Gln res-
idues for Lys or Arg residues to demonstrate the importance
of carboxy terminal basic residues in Ras membrane target-
ing (Hancock et al., 1990; Jackson et al., 1994). To assess the
contribution of the basic amino acids in Chp localization, we
introduced single Gln substitutions for Lys and/or Arg res-
idues at positions 226, 228, 230, and 231 in the rat Chp
protein and designated Chp(226Q), Chp(228Q), Chp(230Q),
and Chp(231Q), respectively. We also created mutant pro-
teins with tandem substitutions [Chp(226Q/228Q) and
Chp(230Q/231Q)] as well as a mutant with Gln substitutions
at all four basic residues, designated Chp(4Q) (Figure 3B).
To determine the contribution of these basic amino acids
to Chp plasma membrane association and subcellular local-
ization, we generated expression vectors encoding GFP-
Figure 3. Conserved residues in the carboxy termini of
Chp and Wrch-1. (A) Sequence comparison of ortho-
logues of Chp and Wrch-1 reveals the presence of con-
served residues that may also play an important role in
the membrane-targeting function of the Chp carboxy
terminus. Gray boxes indicate amino acids that were
mutated to aid in understanding of Chp membrane
targeting. Arrows delineate basic amino acids that are
conserved between Chp orthologues and homologues.
Asterisk indicates Arg residue that is incompletely con-
served between Chp homologues. Mm, Mus musculus
(mouse); Rn, Rattus norvegicus (rat); Hs, Homo sapiens
(human); Cd, Canis domesticus (dog); Pt, Pan troglodyte
(chimp); Gg, Gallus gallus (chicken); Dr, Danio rerio (ze-
brafish). (B) Missense mutations were engineered in the
carboxy terminus of Chp to evaluate the importance of
basic amino acids as well as a conserved Leu, Ser, and
Trp residues at positions 224, 225, and 229, respectively,
in Chp localization. The terminal Val [Chp(236Stop)]
was also removed to determine whether, as with the
CAAX motif, the distance of the Cys residue from the
carboxy terminus is critical for proper membrane tar-
geting and localization.
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Figure 4.
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tagged versions of each Chp mutant protein. NIH 3T3 cells
transiently transfected with the GFP empty vector or encod-
ing wild-type or mutant Chp proteins were then used for
live cell fluorescence analyses of GFP expression (Figure 4).
As we described previously, GFP alone showed nuclear and
cytoplasmic localization, whereas GFP-Chp showed local-
ization to both the plasma membrane and to endomembrane
structures (Chenette et al., 2005). In contrast to GFP-Chp, we
found that GFP-Chp(226Q) and GFP-Chp(228Q) showed an
intermediate phenotype, with significantly diminished
plasma membrane association, increased cytoplasmic local-
ization, but retention of endomembrane localization. Partial
plasma membrane association was seen in 30% of cells that
expressed GFP-Chp(226Q), and a slight majority (60%) of
cells that expressed GFP-Chp(228Q). However, the extent of
plasma membrane association (e.g., proportion of mem-
brane that contained Chp) was significantly decreased com-
pared with wild-type Chp. The double mutant [Chp(226Q/
228Q)] exhibited no plasma membrane binding, diminished
association with endomembranes, and significantly increased cy-
toplasmic localization. This localization pattern is represen-
tative of 100% of the cells examined. Mutation of residues
230 or 231 [GFP-Chp(230Q) and GFP-Chp(231Q)] exhibited a
phenotype similar to the Chp(226Q/228Q) mutant, with no
association with the plasma membrane, increased cytoplas-
mic localization, and modest retention of association with
endomembranes or vesicles. The double Chp(230Q/231Q)
mutant exhibited a similar pattern, although with increased
cytoplasmic localization. Less than half of cells (30%) ex-
amined exhibited a total lack of endomembrane localization.
Not surprisingly, GFP-Chp 4Q was mislocalized to the nu-
cleo- and cytoplasm in 100% of cells visualized, demonstrat-
ing the importance of basic residues in Chp localization.
The Invariant Carboxy-Terminal Tryptophan Residue Is
Essential for Chp Subcellular Location
There are several other nonbasic amino acids that are con-
served between Chp orthologues (arrows) (Figure 3A). We
were especially interested in the contribution of a Trp residue
at position 229, conserved in all Chp/Wrch proteins and not
found in the carboxy termini of other Rho GTPases (except
RhoD). To test the importance of this conserved residue in Chp
localization, we created a GFP-Chp(229Y) mutant and visual-
ized its localization in live NIH 3T3 cells. Interestingly, GFP-
Chp(229Y) was mislocalized to the cyto- and nucleoplasm in
100% of cells visualized (Figure 4). This altered localization is
essentially identical to that seen with C-Chp, where the entire
carboxy-terminal sequence is deleted (Chenette et al., 2005).
There are no known modification events that occur on Trp
residues, so it is possible that the tryptophan is required for
recognition by a protein acyltransferase (PAT) enzyme.
We also evaluated the consequence of mutation of con-
served leucine and serine residues at positions 224 and 225,
respectively (Figure 4). An alanine point mutation at either
of these sites had no effect on localization in any of the cells
examined, suggesting that these residues are not part of the
carboxy-terminal targeting motif of Chp.
Other Rho GTPases require an intact CAAX motif for
recognition by protein prenyltransferases. Removal of the
-X residue results in a lack of prenylation and cytoplasmic
mislocalization of the GTPase (Jackson et al., 1994). Although
Chp lacks a CAAX motif, we determined the importance of
the terminal residues in Chp localization. As seen in Figure
4, removal of the terminal valine had no effect on Chp
localization in any of the cells examined, further emphasiz-
ing the unique properties of the carboxy terminus of Chp.
Basic and Conserved Amino Acids Are Not Part of the
Protein Acyltransferase Recognition Motif
One simple explanation for the mislocalization seen with the
Chp basic residue mutants is that the basic and conserved
residues comprise part of the protein acyltransferase recogni-
tion motif. Aside from the cysteine residue, however, no clear
consensus sequence for the carboxy-terminal PAT motifs of
small GTPases has been established (Smotrys and Linder,
2004). To determine the importance of carboxy-terminal resi-
dues in protein palmitoylation, we used an assay to detect
posttranslational palmitoylation of Chp and Chp mutant pro-
teins that involved hydrolyzing the thioester bond that links
palmitate groups to cysteines and treating with a biotinylated
compound that recognizes and binds to the free sulfhydryl
group generated upon cleavage of the thioester bond (Drisdel
and Green, 2004). We applied this assay previously to demon-
strate the palmitate modification of Chp and Wrch-1 (Berzat et
al., 2005; Chenette et al., 2005). As expected, we were able to
detect labeling of H-Ras, which is palmitoylated, but not K-Ras
or GFP, which are not palmitoylated (Figure 5). As we found
Figure 4 (facing page). Chp membrane localization is dependent
on basic amino acids. (A) NIH 3T3 cells were transiently transfected
with 0.5 g of the pEGFP expression vector encoding GFP fusion
proteins of the indicated Chp proteins. Live cells were visualized
20 h after transfection using a Zeiss 510 LSM confocal microscope.
Images shown are representative of at least two independent exper-
iments, with 50 cells examined in each assay. Bars, 10 m. (B)
Summary of mutations engineered in the carboxy terminus of Chp
and the effect of each mutation on subcellular localization of GFP-
Chp. PM, plasma membrane; cyto, cytoplasm.
Figure 5. Basic residues are not part of the protein
acyltransferase motif. 293T cells were transiently trans-
fected with the indicated pEGFP constructs, lysed 48 h
after transfection, and subjected to a biotin-BMCC la-
beling assay (Drisdel and Green, 2004). Nonpalmitoy-
lated K-Ras was included as a negative control for this
assay (top). An anti-GFP Western blot shows that equiv-
alent concentration of GFP and GFP-tagged versions of
Chp, Chp(229Y), Chp(230Q), Chp(231Q), Chp(4Q), K-
Ras, and H-Ras protein was used in the assays (bottom).
Data shown are representative of three independent
experiments.
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previously, we were able to detect palmitate modification of
Chp. Interestingly, we were able to detect palmitoylation of
four Chp mutants with altered localization phenotypes (Chp
229Y, 230Q, 231Q, and 4Q), suggesting that the mislocalization
of the Chp basic residue mutants is not due to a lack of
palmitoylation.
Basic Amino Acids Are Required for Chp Transforming
Activity
We previously demonstrated that amino-terminally trun-
cated and GTPase-deficient Chp [N-Chp(40V)] caused
growth transformation of NIH 3T3 cells and that the trans-
forming activity of Chp was dependent on an intact carboxy-
terminal extension. To determine whether mutation of the
basic or conserved amino acids in the carboxy terminus of
Chp affected Chp transforming activity, we subjected mass
populations of NIH 3T3 cells that stably expressed Chp,
N-Chp(40V), N-Chp(40V/229Y), N-Chp(40V/230Q),
and N-Chp(40V/231Q) (Figure 6A) to a soft agar assay to
monitor anchorage-independent growth potential. As we
described previously, cells that express wild-type Chp were
unable to facilitate colony formation in soft agar, whereas
cells that express N-Chp(40V) formed many multicellular
colonies (Figure 6B). Mutation of the conserved tryptophan
residue (229Y) or the basic residues at positions 230 or 231
inhibited the ability of activated Chp to promote anchorage-
independent growth. Although our transient expression
analyses indicated that these mutations did not alter protein
stability (Figure 5), we did find that their steady-state levels
were lower than that of N-Chp(40V) (Figure 6A). Thus,
although reduced level of expression may contribute to their
diminished transforming activity, we also suggest that these
results support the importance of proper localization for
Chp transforming activity. Additionally, we suggest that par-
tial Chp localization to endosomal structures [as seen in
Chp(230Q) and Chp(231Q)] is still not sufficient to promote
activation of effector pathways important for transformation.
The Carboxyl Terminal 11 Residues of Chp Are Sufficient
to Promote Chp Subcellular Membrane Association
Work done by Michaelson et al. (2001) determined that the
carboxy-terminal 21 amino acids of Cdc42 were sufficient to
target a heterologous protein (GFP) to the same cellular
membranes as authentic Cdc42. Unlike Cdc42, Chp pos-
sesses additional proline-rich amino-terminal sequences that
may be involved in interaction with Src homology domain
3-containing proteins (Shutes et al., 2004). Therefore, it is
possible that the carboxy terminal sequences of Chp alone
may be necessary, but not sufficient, for proper Chp subcel-
lular localization.
To determine whether the carboxy terminus alone is suf-
ficient for localization and to identify the minimum mem-
brane targeting sequence of Chp, we generated a series of
GFP fusion proteins that terminated with different lengths of
the Chp carboxy terminus (Figure 7A), including 7-amino
acid, 11-amino acid, 15-amino acid, and 37-amino acid tails.
The 7-amino acid tail contains the Cys 234, Lys 230, and Lys
231 residues but excludes the Trp that we showed above to
be critical for localization, whereas the 11- and 15-amino
acid tails include the conserved Trp residue and various
portions of the basic motif. The 37-amino acid tail of Chp
corresponds to the 21-amino acid tail of Cdc42. NIH 3T3
cells transiently expressing the indicated GFP-Chp fusion
proteins were used for live cell fluorescence analyses (Figure
7B). The GFP fusion construct containing the seven carboxyl-
terminal amino acids of Chp, including the palmitoylated
Cys 234 residue [GFP-Chp(230-236)], exhibited a diffuse cy-
tosolic localization with no plasma membrane component.
This localization pattern was seen in 100% of cells examined
and is identical to that seen with the Trp mutant of Chp
[GFP-Chp(229Y)]. This finding again demonstrates that pal-
mitoylation alone is not sufficient to promote membrane
association. In contrast, the last 11 amino acids of Chp
[Chp(226-236)] were sufficient to target GFP to both plasma
and endomembranes, in a localization pattern reminiscent of
wild-type Chp. The addition of other upstream residues
[Chp(222-236) and Chp(200-236)] did not further alter the
plasma- and endomembrane localization pattern seen with
Chp(226-236). Thus, the carboxy-terminal 11 amino acids of
Chp are sufficient to promote membrane association and
subcellular localization.
Figure 6. Basic residues are required for Chp transforming activ-
ity. Mass populations of NIH 3T3 cells that stably express the
indicated Chp proteins were established and evaluated for expres-
sion of HA-tagged Chp by Western blot analyses with anti-HA
antibody (A; top). Western blot analyses with anti--actin were
done to verify equivalent total protein for each cell lysate (bottom).
An intervening lane was removed between the mutant and wild-
type Chp proteins in both blots, with crop boundaries as shown in
the figure. (B) Mutant Chp proteins were analyzed for their ability
to promote growth of NIH 3T3 cells in soft agar. The number of
colonies was quantitated after 35 d. Data shown are representative
of three independent experiments, with SE indicated by the bars.
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Chp Subcellular Location Is Not Regulated by RhoGDIs
RhoGDIs form stable complexes with Rho GTPases, in
part by recognizing and masking the isoprenoid moiety,
and render the GTPase cytosolic and inactive. Although
Chp membrane association is not dependent on prenyla-
tion, it is still possible that RhoGDIs may serve as regu-
lators of Chp subcellullar localization. Michaelson et al.
(2001) showed that the expression levels of RhoGDIs were
limiting in the cell and that ectopic overexpression of
RhoGDIs was sufficient to cause mislocalization of Rho
GTPases to the cytosol. We used this same approach to
determine whether coexpression of the three known
RhoGDIs would prevent Chp association with the plasma
membrane. As shown previously, Rac1 was mislocalized to
the cytoplasm following ectopic RhoGDI expression (Figure
8). In contrast, Chp localization was not disrupted by coex-
pression of RhoGDI-, -, or -, although coexpression of
RhoGDI- severely affects cell morphology. These results
suggest that, unlike Cdc42, Chp is not a target for regulation
by RhoGDIs, as was expected based on its unusual carboxy
terminus.
DISCUSSION
Variations in carboxy-terminal sequences and posttransla-
tional modifications promote the divergent biological prop-
erties of otherwise highly related Rho GTPases (Figure 9). In
the present study, we found that stimulation with TNF-
caused carboxy-terminus–dependent activation of endo-
some- but not plasma membrane-associated Chp. We deter-
mined that basic residues as well as a conserved tryptophan
residue are required for proper Chp subcellular localization
and transformation, but they are not essential for palmitate
modification. Additionally, unlike the classical Rho GTPases,
Chp membrane association is not regulated by RhoGDIs. To-
gether, these observations demonstrate that the membrane-
targeting function of Chp is complex and distinct from that of
other human Rho family GTPases.
The activation of the classical Rho GTPases involves ex-
tracellular stimulus-mediated activation of various cell sur-
face receptors. Previously, Abo and colleagues found that
TNF- caused Chp-dependent JNK activation (Aronheim et
al., 1998). Because we found Chp localized to both the
plasma membrane and to endomembranes, we wanted to
Figure 7. The last 11 amino acids of Chp are necessary and sufficient for membrane targeting. (A) Truncation mutants were engineered to
determine the minimal region of the carboxy terminus of Chp that was sufficient to target a heterologous protein (GFP) to cellular membranes.
(B) NIH 3T3 cells were transiently transfected with 0.5 g of the pEGFP expression vector encoding GFP fusion proteins that terminate with
the indicated Chp carboxy-terminal sequences. GFP fluorescence in live cells was visualized 20 h after transfection using a Zeiss 510 LSM
confocal microscope. Images are shown in duplicate and are representative of at least three independent experiments, with 50 cells
examined in each assay.
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determine which subcellular pool might be activated by
TNF-. We applied an approach developed by Philips and
colleagues to evaluate the spatial distribution of activated
Ras (Philips, 2005) to perform a similar analysis with Chp.
Surprisingly, we found that TNF- stimulation caused wild-
type Chp activation only at endosomes. These results are
similar to those made with Ras, where different extracellular
stimuli resulted in activation of either plasma membrane or
Golgi localized Ras (Bivona et al., 2003). Because Src and
Cdc42 activation also caused Chp-dependent JNK activation
(Aronheim et al., 1998), it will be interesting to determine
whether these, or other signals, can activate plasma mem-
brane-associated Chp.
We determined that basic residues likely comprise a sec-
ond signal, which, together with palmitoylation, can facili-
tate effective and functional membrane targeting. Although
this combination of signals has not been described for any
mammalian Ras or Rho family GTPase, similar genetically
engineered sequences have been shown to target Ras pro-
teins to cellular membranes (Mitchell et al., 1994; Booden et
Figure 8. Chp membrane association is not regulated by RhoGDIs. NIH 3T3 cells were transiently transfected with 0.5 g of the indicated
GFP-tagged construct and 1 g of pcDNA3.1 expression plasmid DNA encoding the indicated RhoGDI. Images shown are representative of
at least three independent experiments, with 50 cells examined per assay. Live cells were visualized and photographed 20 h after
transfection using a Zeiss 510 LSM confocal microscope.
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al., 1999). For example, Deschenes and colleagues deter-
mined that yeast RAS2 terminating with a CCIIKLIKRK
sequence no longer underwent prenylation, but it retained
wild-type membrane association and function (Mitchell et
al., 1994).
Our analyses of the role of individual basic residues in
Chp function revealed two unexpected findings. First, we
found that mutation of a single basic residue (K230Q or
K231Q) abolished Chp association with the plasma mem-
brane. These results contrast with observations made with
K-Ras4B, where mutation of multiple basic residues was
required to disrupt its targeting function: mutation of two of
the six basic residues in the carboxy terminus of K-Ras4B did
not significantly alter the subcellular localization of K-Ras,
and 50% of mutant K-Ras4B was able to reach cellular
membranes upon replacement of the entire polybasic do-
main with glutamine residues (Jackson et al., 1994). One
possible explanation for this difference may be that the bond
between palmitate and cysteine is dynamic and reversible,
whereas the prenyl-cysteine bond is permanent and irre-
versible (Mumby, 1997; Bijlmakers and Marsh, 2003; Linder
and Deschenes, 2003). Therefore, it is possible that Chp is
less tightly associated with the plasma membrane and has
an increased dependency on basic residues to maintain its
membrane association. Consistent with this possibility,
Booden et al. (1999) found that a variant Ras protein that was
targeted to membranes by palmitoylation, and basic resi-
dues showed only partial membrane association compared
with the authentic prenylated Ras protein. We also found
that the basic residues are more critical for Chp association
with the plasma membrane than with endomembranes.
In addition to the palmitoylated cysteine and basic resi-
dues, our sequence alignment of the carboxy termini of Chp
homologues and orthologues identified additional con-
served residues that we speculated might be important for
Chp subcellular location and function. We found that a
conserved tryptophan residue was critical for Chp localiza-
tion and transforming activity. Tryptophan residues have
not been described to be important in the subcellular local-
ization of other small GTPases; perhaps this Trp residue
comprises a novel membrane-targeting motif. Thus, we
speculate that this residue may constitute a third carboxy
terminal element that, together with basic residues and pal-
mitoylation, is essential to promote Chp function. Our find-
ing that Chp membrane association is mediated by three
separate signals expands the known mechanisms of car-
boxy-terminal directed membrane targeting to at least six
distinct motifs (Figure 9).
One possible role of the tryptophan and basic residues is
that they comprise the sequence that signals for Chp palmi-
toylation. However, we found that none of the Chp mutants
tested was defective in palmitate modification. Therefore,
we conclude that the mislocalization of Chp mutants is not
due to lack of palmitoylation but rather to loss of net posi-
tive charge in the carboxy terminus (as is the case with
mutant K-Ras [Jackson et al., 1994] and the basic Chp mu-
tants) or some other unknown mechanism (in the case of the
Trp mutant).
We determined that the carboxy-terminal 11 amino acids
of Chp were sufficient to direct a heterologous protein, GFP,
to the same gross membrane and subcellular location as
wild-type Chp. This result implies that these amino acids are
involved in critical associations with the plasma membrane.
Comparing the sequences of GFP-Chp(230-236) (no mem-
brane association) to GFP-Chp(226-236) (plasma and endo-
membrane association) reveals that a few amino acids may
tip the balance toward membrane association. Predictably,
these amino acids include the two basic residues that we
showed were important for membrane targeting (R226 and
R228) as well as the tryptophan residue (W229) that was
essential for proper localization. Future studies will be di-
rected toward determining the importance of these individ-
ual residues in dictating endosome versus plasma mem-
brane localization of Chp.
Our finding that Chp is not a target for mislocalization by
RhoGDIs is not entirely surprising. RhoGDIs recognize
Cdc42 and other Rho family GTPases and extract them from
membranes. RhoGDI association with GTPases requires an
Figure 9. Rho GTPase carboxy-terminal membrane-targeting se-
quences. The greatest sequence divergence between otherwise closely-
related Rho GTPases lies in the hypervariable (HV) motif at the
carboxy terminus of the protein. Specific sequences in the HV motif
signal for posttranslational modifications and direct localization of
Rho GTPases to distinct membrane compartments. The majority (16
of 20) of human Rho family GTPases terminates with CAAX motifs
that signal for modification by either farnesyl (F) or geranylgeranyl
(G) isoprenoids, AAX proteolysis, and carboxymethylation (O-Me).
These GTPases also possess a second membrane-targeting signal:
dual palmitoylated cysteines (P), positively charged amino acid
stretches (polybasic K/R), or a combination of both signals. Chp
lacks a CAAX motif and is modified by palmitoylation of a single
cysteine. At least two additional carboxy-terminal sequence ele-
ments (polybasic amino acids and an invariant tryptophan residue)
are required for Chp subcellular membrane localization. RhoBTB
proteins lack any known carboxy-terminal lipid modifications and
instead terminate with tandem BR-C, ttk, and bab (BTB) domains.
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isoprenyl moiety at the carboxy terminus of the protein
(DerMardirossian and Bokoch, 2005). Because Chp does not
undergo prenylation, RhoGDIs may not be able to recognize
Chp. Furthermore, RhoGDI recognition is also dependent on
specific sequences in the switch II domain of Rho GTPases
(Hoffman et al., 2000). Because Chp shows divergence in these
sequences compared with Cdc42, the failure of RhoGDIs to
recognize Chp may be due to both primary sequence diver-
gence and the lack of isoprenoid modification. Clearly, the
regulation of Chp is a complex issue, most likely managed by
multiple interactions at the carboxy terminus of the protein.
In conclusion, the data presented here exemplify the com-
plex and multifaceted mechanisms of regulation of Rho
GTPase membrane association. Canonical Rho GTPases rely
on prenylation in combination with palmitoylated cysteines
and/or positively charged residues for proper localization.
In contrast, Chp function requires palmitoylation, basic res-
idues, and an invariant tryptophan residue for proper sub-
cellular localization. The unprecedented way by which Chp
reaches cellular membranes as well as its insensitivity to
RhoGDI regulation further emphasizes the idiosyncratic
means of localization of the Rho family of small GTPases. It
also illuminates how otherwise highly conserved proteins
achieve distinct subcellular localization profiles and biolog-
ical functions.
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